Eton Pharmaceutcials
ETON
32 hedge funds and large institutions have $12.3M invested in Eton Pharmaceutcials in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
10% more funds holding
Funds holding: 29 → 32 (+3)
1.62% more ownership
Funds ownership: 23.46% → 25.08% (+1.6%)
16% less capital invested
Capital invested by funds: $14.6M → $12.3M (-$2.27M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$316K |
| 2 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$249K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$230K |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$146K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$129K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$62.3K |
| 2 |
PP
PDT Partners
New York
|
-$40K |
| 3 |
VF
Virtu Financial
New York
|
-$20.9K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$19.7K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$17.9K |
ETON Hedge Fund Activity: Q3 2022 in Review
32 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q3 2022, worth a combined $12.3M — down 16% from $14.6M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ETON positions and 1 closed out — a net gain of 3 holders — while 8 added to existing stakes and 7 trimmed.
The largest buyer was Westside Investment Management, adding an estimated $316K. The largest seller was Bridgeway Capital Management, cutting an estimated $62.3K.
- 32 institutional investors held Eton Pharmaceutcials (ETON) as of Q3 2022, up from 29 in Q2 2022.
- Funds reported $12.3M of Eton Pharmaceutcials stock for Q3 2022, down 16% quarter-over-quarter.
- 4 funds opened new Eton Pharmaceutcials positions in Q3 2022 and 1 closed out, a net change of +3 holders.
- The largest Eton Pharmaceutcials buyer in Q3 2022 was Westside Investment Management, an estimated $316K added.
- The largest Eton Pharmaceutcials seller in Q3 2022 was Bridgeway Capital Management, an estimated $62.3K sold.
Based on aggregated 13F filings for Q3 2022.